Login

Realm Therapeutics plc - Equity Development Investor Forum - Alex Martin, CEO, Realm Therapeutics 00:00:00

Share On Facebook Share On Twitter

Realm Therapeutics plc - Equity Development Investor Forum

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Unlock AI-Driven Marketing Secrets: Register for Our Free Webinar
00:10:00
Robert Friedland Discusses the Urgent Need for Copper in the Green Transition
00:10:00
Private Equity Fund Essentials: Insights from Simpson Thacher Experts | Alden Millard - Partner,Chair of the Executive Committee of Simpson Thacher
00:10:00
Solaris Resources: Copper Growth and Discovery Strategy Overview
00:10:00
Role and Responsibilities of a Senior Operating Partner in Private Equity
00:10:00
Beleave Inc. CFO Bojan Krasic Discusses Recent Developments and Expansion Plans | Bojan Krasic, CFO, Beleave Inc.
00:10:00
Morgan Stanley CEO Transition: James Gorman and Ted Pick on Leadership and the Future
00:10:00
Abel Takes Helm at Public Investment Corporation Amidst Turbulence | Abel Sithole, CEO , Public Investment Corporation.
00:10:00
Hank Smith, CIO at Haverford Trust Co., discusses U.S. stock performance and its broader economic impact.
00:10:00
Steve Steinour, Chairman, President, and CEO of Huntington Bancshares, discusses the state of banking and lending on "Mad Money" with Jim Cramer.
00:10:00
Multichoice Group CEO Calvo Mawela discussed the company's initiatives to boost African start-ups and enhance their global visibility during a CNBC interview.
00:00:00
Dr. Donna Skerrett, CEO, Paradigm Biopharmaceuticals Ltd

© 2026 Nehu